Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...

Antiepileptic Drugs: Glutamate Antagonists

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Discovery of VU6053371/BI03738809: A First-in-Class Selective and CNS-Penetrant mGlu<sub>3</sub> Positive Allosteric Modulator (PAM) with Efficacy in a Preclinical Cognition Model.

ACS chemical neuroscience·2026

Same author

Discovery of 7-(Pyridin-3-yl)thieno[3,2-<i>b</i>]pyridine-5-carboxamides as Negative Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 5.

ACS chemical neuroscience·2026

Same author

Discovery of VU6025733 (AG06827): A Highly Selective, Orally Bioavailable, and Structurally Distinct M<sub>4</sub> Muscarinic Acetylcholine Receptor Positive Allosteric Modulator (PAM) with Robust <i>In Vivo</i> Efficacy.

ACS chemical neuroscience·2026

Same author

Discovery of VU6052254: A Novel, Potent M<sub>1</sub> Positive Allosteric Modulator.

ACS chemical neuroscience·2025

Same author

Muscarinic Acetylcholine Receptor Activators as Transformative Therapeutics for Schizophrenia.

Annual review of medicine·2025

Same author

Investigating the role of rostral pedunculopontine nucleus M<sub>4</sub> receptors in motor deficits and dyskinesia in hemiparkinsonian rats.

Behavioural brain research·2025

Search research articles

Related Experiment Video

Updated: Mar 24, 2026

A High-throughput Calcium-flux Assay to Study NMDA-receptors with Sensitivity to Glycine/D-serine and Glutamate

A High-throughput Calcium-flux Assay to Study NMDA-receptors with Sensitivity to Glycine/D-serine and Glutamate

Published on: July 10, 2018

Novel PAMs Targeting NMDAR GluN2A Subunit.

Zixiu Xiang¹, P Jeffrey Conn¹

¹Department of Pharmacology, Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University, Nashville, TN 37232, USA.

|March 4, 2016

Summary

Researchers discovered new positive allosteric modulators (PAMs) that selectively target GluN2A-containing NMDA receptors. These novel PAMs significantly impact synaptic plasticity, offering new avenues for neurological research.

Area of Science:

Neuroscience
Molecular Biology
Pharmacology

Background:

NMDA receptors are crucial for synaptic plasticity and cognitive functions.
Dysfunction of NMDA receptors is implicated in various neurological disorders.
Targeting specific NMDA receptor subunits offers potential for selective therapeutic interventions.

Purpose of the Study:

To discover and characterize novel positive allosteric modulators (PAMs) for NMDA receptors.
To investigate the subunit selectivity of these novel PAMs, particularly for GluN2A-containing receptors.
To explore the effects of these PAMs on synaptic plasticity.

Main Methods:

High-throughput screening for identification of PAMs.
Electrophysiological recordings to assess NMDA receptor function.

More Related Videos

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission

Published on: August 16, 2018

An Antibody Feeding Approach to Study Glutamate Receptor Trafficking in Dissociated Primary Hippocampal Cultures

An Antibody Feeding Approach to Study Glutamate Receptor Trafficking in Dissociated Primary Hippocampal Cultures

Published on: August 2, 2019

Related Experiment Videos

Last Updated: Mar 24, 2026

A High-throughput Calcium-flux Assay to Study NMDA-receptors with Sensitivity to Glycine/D-serine and Glutamate

A High-throughput Calcium-flux Assay to Study NMDA-receptors with Sensitivity to Glycine/D-serine and Glutamate

Published on: July 10, 2018

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission

Published on: August 16, 2018

An Antibody Feeding Approach to Study Glutamate Receptor Trafficking in Dissociated Primary Hippocampal Cultures

An Antibody Feeding Approach to Study Glutamate Receptor Trafficking in Dissociated Primary Hippocampal Cultures

Published on: August 2, 2019

Biochemical assays to confirm subunit selectivity.

In vitro and in vivo models to study effects on synaptic plasticity.

Main Results:

Discovery of a novel class of positive allosteric modulators (PAMs).
These PAMs exhibit high selectivity for GluN2A-containing NMDA receptors.
The identified PAMs demonstrate distinct effects on synaptic plasticity.

Conclusions:

The novel PAMs represent a significant advancement in targeting GluN2A-containing NMDA receptors.
These findings provide new tools for studying NMDA receptor function and synaptic plasticity.
This discovery holds potential for developing treatments for neurological conditions associated with NMDA receptor dysfunction.